SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-022756
Filing Date
2016-08-04
Accepted
2016-08-04 17:25:28
Documents
77
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q rptp-10q_20160630.htm 10-Q 1896124
2 EX-31.1 rptp-ex311_7.htm EX-31.1 8862
3 EX-31.2 rptp-ex312_8.htm EX-31.2 8959
4 EX-32.1 rptp-ex321_6.htm EX-32.1 8891
  Complete submission text file 0001564590-16-022756.txt   7708329

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT rptp-20160630.xml EX-101.INS 1747329
6 XBRL TAXONOMY EXTENSION SCHEMA rptp-20160630.xsd EX-101.SCH 59784
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rptp-20160630_cal.xml EX-101.CAL 58946
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rptp-20160630_def.xml EX-101.DEF 181781
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE rptp-20160630_lab.xml EX-101.LAB 431967
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rptp-20160630_pre.xml EX-101.PRE 345920
Mailing Address 7 HAMILTON LANDING SUITE 100 NOVATO CA 94949
Business Address 7 HAMILTON LANDING SUITE 100 NOVATO CA 94949 415-408-6200
Raptor Pharmaceutical Corp (Filer) CIK: 0001070698 (see all company filings)

IRS No.: 860883978 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-25571 | Film No.: 161808501
SIC: 2834 Pharmaceutical Preparations